European Organisation for Research and Treatment of Cancer (EORTC)
Research / Science organisation
Location:
Brüssel (Brussels),
Belgium (BE)
ISNI: 0000000406100854
ROR: https://ror.org/034wxcc35
Show on Map:
TREAT CTC: An innovative therapy approach to eliminate circulating tumor cells (CTCs) (2016)
Tzschaschel M, Trapp E, Rack B, Messina C, Mueller V, Fehm T, Janni W, et al.
Conference contribution
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project+ (2015)
Kramar A, Negrier S, Sylvester R, Joniau S, Mulders P, Powles T, Bex A, et al.
Journal article
Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer (2015)
Valentini V, Van Stiphout RGPM, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, et al.
Journal article
Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial (2014)
Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, et al.
Journal article
Assessing the quality of studies on the diagnostic accuracy of tumor markers (2014)
Goebell P, Kamat AM, Sylvester RJ, Black P, Droller M, Godoy G, Hudson MA, et al.
Journal article
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis (2014)
Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, et al.
Journal article